Clinical Trials Browser

Lymphangioma, Lymphangioma, Cystic, Lymphatic Abnormalities

NCT06239480 2026-03-27

SELVA

Phase 3 Active not recruiting

51 enrolled

Congenital Abnormalities, Lymphangioma, Lymphatic Abnormalities, Vascular Malformations

NCT07477548 2026-03-17

A Study to Evaluate the Efficacy and Safety of Everolimus in Patients With Teratment-refractory Vascular Anomalies

Phase 2 Not yet recruiting

67 enrolled

Arteriovenous Malformations, Hemangioendothelioma, Hemangioma, Lymphangioma, Nevus, Vascular Malformations

NCT05983159 2026-02-19

TARGET-VM

Phase 2 Recruiting

50 enrolled

Arteriovenous Malformations, Lymphangioma, Skin Diseases, Vascular, Lymphangioma, Cystic, Lymphatic Abnormalities, Vascular Malformations

NCT00975819 2026-01-06

Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies

Phase 2 Completed

61 enrolled 7 charts

Classical hematology

Tufted angioma, Lymphangioma, Thrombocytopenia

NCT06943703 2025-04-24

Bleomycin as an Effective and Curative Adjunct Therapy for Lymphangioma

Completed

809 enrolled

Lymphangioma, Lymphatic Abnormalities

NCT06892964 2025-03-25

IReg-LM

Phase NA Recruiting

70 enrolled

Lymphangioma, Lymphatic Abnormalities

NCT05050149 2025-01-17

Study Evaluating the Safety and Efficacy of PTX-022 (QTORIN Sirolimus) in the Treatment of Microcystic Lymphatic Malformations

Phase 2 Completed

12 enrolled 7 charts

Lymphangioma

NCT06257719 2024-02-14

Clinical Characteristics of Lymphatic Malformations

Completed

320 enrolled

Abdomen, Acute, Lymphangioma, Lymphatic Abnormalities

NCT03941782 2024-01-11

Compassionate Use of BYL 719 Alpelisib

No longer available

Lymphangioma

NCT06160739 2023-12-15

Role of Sirolimus in Treatment of Microcystic , Mixed Lymphatic and Vascular Malformations

Unknown

10 enrolled

Lymphangioma, Vascular Malformations

NCT01290484 2015-06-19

A Study to Evaluate Sildenafil for the Treatment of Lymphatic Malformations

Phase 1/2 Completed

7 enrolled 5 charts

Lymphangioma, Lymphatic Abnormalities, Vascular Malformations

NCT00010452 2015-03-25

Study of Picibanil (OK432) Sclerotherapy in Children With Macrocystic Lymphatic Malformations

Phase 2/3 Completed

150 enrolled